MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 04.11.2025
Baxter International EV/EBITDA 2011-2026 | BAX
EV/EBITDA Jährlich Baxter International
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 24.7 | 17.5 | 28.9 | 16.4 | 19.4 | 16.8 | 20.1 | 7.3 | 7.7 | 6.5 | 5.36 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 28.9 | 5.36 | 15.5 |
EV/EBITDA anderer Aktien in der Medizinische Instrumente
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
25.8 | - | - | $ 810 M |  USA |
 |
Becton, Dickinson and Company
BDX
|
13.6 | $ 195.0 | 0.49 % | $ 56.1 B | USA |
 |
Luminex Corporation
LMNX
|
15.9 | - | - | $ 1.75 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
0.307 | $ 8.13 | -5.9 % | $ 164 M | USA |
 |
Akers Biosciences, Inc.
AKER
|
-0.0238 | - | -9.52 % | $ 20.6 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
44 | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
24.9 | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
6.47 | - | - | $ 282 M | USA |
 |
Harvard Bioscience
HBIO
|
70.9 | $ 0.66 | -0.9 % | $ 28 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
14.8 | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
252 | - | -0.02 % | $ 16.3 B | USA |
 |
Repro Med Systems
KRMD
|
-17.1 | $ 5.58 | -3.96 % | $ 254 M | USA |
 |
Alcon
ALC
|
72.7 | $ 77.69 | -1.42 % | $ 40.4 B |  Schweiz |
 |
AtriCure
ATRC
|
48.1 | $ 39.19 | -0.94 % | $ 1.84 B | USA |
 |
Merit Medical Systems
MMSI
|
25 | $ 86.9 | -1.41 % | $ 5.06 B | USA |
 |
ICU Medical
ICUI
|
23.5 | $ 139.1 | -2.5 % | $ 3.39 B | USA |
 |
electroCore
ECOR
|
1.45 | $ 4.54 | 1.23 % | $ 25 K | USA |
 |
iRhythm Technologies
IRTC
|
-38.7 | $ 175.59 | -1.04 % | $ 5.48 B | USA |
 |
AngioDynamics
ANGO
|
-102 | $ 12.64 | -1.56 % | $ 516 M | USA |
 |
Isoray
ISR
|
18.4 | - | 0.03 % | $ 108 M | USA |
 |
The Cooper Companies
COO
|
34.6 | $ 81.37 | -0.72 % | $ 16.2 B | USA |
 |
Nephros
NEPH
|
-8.71 | $ 4.78 | -2.15 % | $ 49.6 M | USA |
 |
Glaukos Corporation
GKOS
|
-908 | $ 111.02 | -1.67 % | $ 5.38 B | USA |
 |
LeMaitre Vascular
LMAT
|
22.8 | $ 80.78 | -0.39 % | $ 1.81 B | USA |
 |
Haemonetics Corporation
HAE
|
12.9 | $ 80.15 | - | $ 4.03 B | USA |
 |
InfuSystem Holdings
INFU
|
15.8 | $ 8.46 | -5.58 % | $ 175 M | USA |
 |
Masimo Corporation
MASI
|
40.8 | $ 127.63 | -1.87 % | $ 6.8 B | USA |
 |
Intuitive Surgical
ISRG
|
49.3 | $ 562.18 | -0.74 % | $ 200 B | USA |
 |
OraSure Technologies
OSUR
|
361 | $ 2.37 | -2.27 % | $ 176 M | USA |
 |
Microbot Medical
MBOT
|
-2.17 | $ 2.09 | 4.69 % | $ 21.3 M |  Israel |
 |
Milestone Scientific
MLSS
|
-7.89 | $ 0.29 | 6.23 % | $ 23.1 M | USA |
 |
STERIS plc
STE
|
29.7 | $ 251.21 | -0.91 % | $ 24.8 B | USA |
 |
NeuroMetrix
NURO
|
-2.11 | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
15.7 | $ 21.74 | 0.09 % | $ 3.74 B | USA |
 |
Stereotaxis
STXS
|
-28.2 | $ 2.32 | 0.65 % | $ 187 M | USA |
 |
Pro-Dex
PDEX
|
20.7 | $ 37.63 | -2.21 % | $ 124 M | USA |
 |
Predictive Oncology
POAI
|
1.29 | - | - | $ 32.4 M | USA |
 |
Pulse Biosciences
PLSE
|
-5.21 | $ 13.26 | -3.46 % | $ 637 M | USA |
 |
Utah Medical Products
UTMD
|
14.1 | $ 57.34 | 2.47 % | $ 208 M | USA |
 |
ResMed
RMD
|
35.2 | $ 245.02 | 1.75 % | $ 35.8 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
11.9 | $ 11.33 | -0.87 % | $ 2.3 B | USA |
 |
Repligen Corporation
RGEN
|
70.6 | $ 163.5 | -0.22 % | $ 9.11 M | USA |
 |
BioLife Solutions
BLFS
|
-38.3 | $ 23.86 | -1.32 % | $ 1.1 B | USA |
 |
Retractable Technologies
RVP
|
3.35 | $ 0.77 | -0.7 % | $ 23.1 M | USA |
 |
STAAR Surgical Company
STAA
|
89 | $ 23.45 | 1.56 % | $ 1.15 B | USA |
 |
Teleflex Incorporated
TFX
|
21.2 | $ 123.04 | 0.79 % | $ 5.76 B | USA |
 |
West Pharmaceutical Services
WST
|
33.1 | $ 276.44 | 0.44 % | $ 20.2 B | USA |